# Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

> **NCT00021424** · PHASE1 · COMPLETED · sponsor: **National Institute on Deafness and Other Communication Disorders (NIDCD)**

## Conditions studied

- Head and Neck Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** recombinant fowlpox-TRICOM vaccine

## Key facts

- **NCT ID:** NCT00021424
- **Lead sponsor:** National Institute on Deafness and Other Communication Disorders (NIDCD)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021424, "Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00021424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*